Chromaviso circadian lighting cuts sick leave up to 21%, InnovationsFonden-backed study shows

• Chromaviso expanded use of its circadian lighting across healthcare sites, supported by DKK 2.7 million in InnovationsFonden-backed research.
• Funding covered an industrial PhD program (2019-2023) of DKK 1.1 million, alongside an international project (2022-2024) of DKK 1.6 million.
• Reported outcomes include up to 71% lower aggressive behavior in some dementia cases, improved sleep, stronger staff well-being, fewer headaches.
• A user survey at a nursing home in Odense showed sick leave falling by up to 21% following installation.
• Chromaviso cited product simplification to cut cost, including a plug-in version, targeting wider rollout across Scandinavia’s 130-plus sites.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InnovationsFonden published the original content used to generate this news brief on August 21, 2026, and is solely responsible for the information contained therein.